Literature DB >> 12297568

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.

D Mungas1, B R Reed, W J Jagust, C DeCarli, W J Mack, J H Kramer, M W Weiner, N Schuff, H C Chui.   

Abstract

OBJECTIVE: To examine volumetric MRI correlates of longitudinal cognitive decline in normal aging, AD, and subcortical cerebrovascular brain injury (SCVBI).
BACKGROUND: Previous cross-sectional studies examining the relationship between cognitive impairment and dementia have shown that hippocampal and cortical gray matter atrophy are the most important predictors of cognitive impairment, even in cases with SCVBI. The authors hypothesized that hippocampal and cortical gray matter volume also would best predict rate of cognitive decline in cases with and without SCVBI.
METHODS: Subjects were recruited for a multicenter study of contributions to dementia of AD and SCVBI. The sample (n = 120) included cognitively normal, cognitively impaired, and demented cases with and without lacunes identified by MRI. Cases with cortical strokes were excluded. Average length of follow-up was 3.0 years. Measures of hippocampal volume, volume of cortical gray matter, presence of subcortical lacunes, and volume of white matter hyperintensity were derived from MRI. Random effects modeling of longitudinal data was used to assess effects of baseline MRI variables on longitudinal change in a measure of global cognitive ability.
RESULTS: Cortical gray matter atrophy predicted cognitive decline regardless of whether lacunes were present. Hippocampal atrophy predicted decline only in those without lacunes. Neither lacunes nor white matter hyperintensity independently predicted decline.
CONCLUSIONS: Results suggest that cortical atrophy is an index of disease severity in both AD and subcortical cerebrovascular brain injury and consequently predicts faster progression. Hippocampal volume may index disease severity and predict progression in AD. The absence of this effect in cases with lacunes suggests that this group is etiologically heterogeneous and is not composed simply of cases of AD with incidental stroke.

Entities:  

Mesh:

Year:  2002        PMID: 12297568      PMCID: PMC1820873          DOI: 10.1212/wnl.59.6.867

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  The effects of additional pathology on the cognitive deficit in Alzheimer disease.

Authors:  Z Nagy; M M Esiri; K A Jobst; J H Morris; E M King; B McDonald; C Joachim; S Litchfield; L Barnetson; A D Smith
Journal:  J Neuropathol Exp Neurol       Date:  1997-02       Impact factor: 3.685

3.  Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas.

Authors:  J W Haller; A Banerjee; G E Christensen; M Gado; S Joshi; M I Miller; Y Sheline; M W Vannier; J G Csernansky
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

4.  Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.

Authors:  H Agüero-Torres; L Fratiglioni; Z Guo; M Viitanen; B Winblad
Journal:  J Am Geriatr Soc       Date:  1998-04       Impact factor: 5.562

5.  MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects.

Authors:  M P Laakso; H Soininen; K Partanen; M Lehtovirta; M Hallikainen; T Hänninen; E L Helkala; P Vainio; P J Riekkinen
Journal:  Neurobiol Aging       Date:  1998 Jan-Feb       Impact factor: 4.673

6.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

7.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

Authors:  D A Snowdon; L H Greiner; J A Mortimer; K P Riley; P A Greiner; W R Markesbery
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

8.  Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.

Authors:  C Ballard; A Patel; F Oyebode; G Wilcock
Journal:  Age Ageing       Date:  1996-05       Impact factor: 10.668

Review 9.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

10.  Hippocampal MR imaging morphometry by means of general pattern matching.

Authors:  J W Haller; G E Christensen; S C Joshi; J W Newcomer; M I Miller; J G Csernansky; M W Vannier
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

View more
  59 in total

1.  Medial temporal lobe function and structure in mild cognitive impairment.

Authors:  Bradford C Dickerson; David H Salat; Julianna F Bates; Monika Atiya; Ronald J Killiany; Douglas N Greve; Anders M Dale; Chantal E Stern; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

2.  Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Dingfen Han; Michelle M Mielke; Sarah N Forrester; JoAnn T Tschanz; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; Constantine G Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-06-12       Impact factor: 3.878

Review 3.  Amyloid positron emission tomography and cognitive reserve.

Authors:  Matteo Bauckneht; Agnese Picco; Flavio Nobili; Silvia Morbelli
Journal:  World J Radiol       Date:  2015-12-28

4.  Longitudinal volumetric MRI change and rate of cognitive decline.

Authors:  D Mungas; D Harvey; B R Reed; W J Jagust; C DeCarli; L Beckett; W J Mack; J H Kramer; M W Weiner; N Schuff; H C Chui
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

5.  Age effects on atrophy rates of entorhinal cortex and hippocampus.

Authors:  An-Tao Du; Norbert Schuff; Linda L Chao; John Kornak; William J Jagust; Joel H Kramer; Bruce R Reed; Bruce L Miller; David Norman; Helena C Chui; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2005-06-14       Impact factor: 4.673

6.  Brain regional lesion burden and impaired mobility in the elderly.

Authors:  Nicola Moscufo; Charles R G Guttmann; Dominik Meier; Istvan Csapo; Peter G Hildenbrand; Brian C Healy; Julia A Schmidt; Leslie Wolfson
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

7.  Medial temporal lobe BOLD activity at rest predicts individual differences in memory ability in healthy young adults.

Authors:  Gagan S Wig; Scott T Grafton; Kathryn E Demos; George L Wolford; Steven E Petersen; William M Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-10       Impact factor: 11.205

8.  Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes.

Authors:  Ling Zheng; Harry V Vinters; Wendy J Mack; Chris Zarow; William G Ellis; Helena C Chui
Journal:  Stroke       Date:  2013-07-25       Impact factor: 7.914

9.  Relationship of clinical and cognitive variables with brain morphometric abnormalities in Alzheimer's disease: a voxel based morphometric study using 3-tesla MRI.

Authors:  Bhavani S Bagepally; John P John; Mathew Varghese; Harsha N Halahalli; Lakshminarayanan Kota; Palanimuthu T Sivakumar; Srikala Bharath; Sanjeev Jain
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

10.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.